发文分析
近年国家/地区发文量统计
| 国家/地区 | 数量 |
|---|---|
| USA | 78 |
| Italy | 35 |
| CHINA MAINLAND | 31 |
| GERMANY (FED REP GER) | 28 |
| France | 23 |
| New Zealand | 19 |
| Spain | 19 |
| Japan | 17 |
| South Korea | 16 |
| England | 14 |
近年机构发文量统计
| 机构 | 数量 |
|---|---|
| UNICANCER | 11 |
| UNIVERSITY OF TEXAS SYSTEM | 11 |
| SPRINGER NATURE | 10 |
| SHANGHAI JIAO TONG UNIVERSITY | 9 |
| FONDAZIONE IRCCS ISTITUTO NAZIONALE TUMORI MIL... | 8 |
| FUDAN UNIVERSITY | 8 |
| SPRINGER NAT | 7 |
| UNIVERSITA DI MODENA E REGGIO EMILIA | 7 |
| UNIVERSITY OF BOLOGNA | 7 |
| UNIVERSITY OF CALIFORNIA SYSTEM | 7 |
近年文章引用他刊数据
| 文章名称 | 引用次数 |
|---|---|
| Liquid-Biopsy-Based Identification of EGFR T790M Mutatio... | 24 |
| Targeting Toll-Like Receptors for Cancer Therapy | 23 |
| PARP Inhibition in Cancer: An Update on Clinical Develop... | 22 |
| Toxicities with Immune Checkpoint Inhibitors: Emerging P... | 22 |
| Inhibiting CDK in Cancer Therapy: Current Evidence and F... | 17 |
| Alpha-Emitters and Targeted Alpha Therapy in Oncology: f... | 14 |
| Medical Treatment Options for Patients with Epidermal Gr... | 14 |
| TRK Inhibition: A New Tumor-Agnostic Treatment Strategy | 14 |
| Evaluation of Clinically Relevant Drug-Drug Interactions... | 12 |
| Distribution of ALK Fusion Variants and Correlation with... | 11 |
近年被他刊引用数据
| 期刊名称 | 引用次数 |
|---|---|
| CANCERS | 45 |
| INT J MOL SCI | 35 |
| TARGET ONCOL | 33 |
| FRONT ONCOL | 23 |
| SCI REP-UK | 22 |
| CELLS-BASEL | 21 |
| FUTURE ONCOL | 20 |
| CANCER MANAG RES | 16 |
| ONCOTARGETS THER | 15 |
| J CELL PHYSIOL | 14 |